Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)
Stock Market Today: Dow Jones, S&P 500 Futures Drop After Supreme Court Strikes Down Trump's Emergency Tariffs— Novo Nordisk, Strategy, Vanda In Focus - State Street SPDR S&P 500 ETF Trust (ARCA:SPY)
Le azioni Vanda Pharmaceuticals salgono dopo l’approvazione FDA del nuovo farmaco per il Disturbo Bipolare I